Pablo J Cagnoni Net Worth

Track Major Insider Updates On X/Twitter

Last Updated: 4 months, 1 week ago

Pablo J Cagnoni has an estimated net worth of at least $21.2 million*, as of Oct. 29, 2025. They own 234,800 shares of INCY stock. They have sold 41,086 shares of INCY stock since 2021, for an estimated $0.

Pablo J Cagnoni $INCY SEC Form 4 Insider Trading

Pablo J Cagnoni has filed a total of 1 insider trades in $INCY since 2021. Their most recent trade was a sale of 18,668 shares, made on Feb 19, 2026. Their largest trade was a sale of 18,668 shares, made on Feb 19, 2026. We estimate that they now own 234,800 shares of $INCY, worth an estimated $21.2 million.

Insider Trading at $INCY

There have been a total of 133 insider trades reported at $INCY since 2021, with 4.1 million shares purchased and 795,826 shares sold. The most active insider traders in $INCY stock have been Sheila A. Denton, Vijay K Iyengar, and Barry P Flannelly. The most recent trade was a sale of 18,668 shares reported by PABLO J CAGNONI (President, R&D), made on Feb 19, 2026.

History of Insider Stock Trades by Pablo J Cagnoni

Company Ticker	Purchase / Sale	Shares	Date	Disclosed (EST)
INCY	Sale	18,668	Feb 19, 2026	Feb. 23, 2026, 5:05 p.m.
RUBY	Sale	8,448	Feb 01, 2023	Feb. 1, 2023, 10:41 p.m.
RUBY	Sale	7,240	Jan 31, 2023	Jan. 31, 2023, 10:51 p.m.
RUBY	Sale	6,730	Feb 01, 2022	Feb. 1, 2022, 10:20 p.m.

$INCY Executives and Stock Owners with Insider Trades

Sheila A. Denton, EVP & General Counsel
Vijay K Iyengar, EVP, GMAPPS
Barry P Flannelly, EVP & General Manager US
Thomas Tray, Principal Accounting Officer
Steven H Stein, EVP & Chief Medical Officer
Maria E Pasquale, EVP & General Counsel
Dashyant Dhanak, EVP & Chief Scientific Officer
Paula J Swain, EVP, Human Resources
Michael James Morrissey, EVP, Head of Tech. Operations
Jonathan Elliott Dickinson, EVP, General Manager, Europe
Patrick A Mayes, EVP & Chief Scientific Officer
Paul Trower, Principal Accounting Officer
Pablo J Cagnoni, President, R&D
Mohamed Khairie Issa, EVP, Head of US Oncology
Lee Heeson, EVP, Head of Incyte Intl
Vijay K Iyengar, EVP GPS, BD, & Licensing
Yao Wenqing, EVP, Head of Discovery Chem

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.